Nathaniel Chin
Host at Dementia Matters
Memory clinic doc @UWHealth. #Alzheimers and #dementia investigator @WisconsinADRC. Host of #DementiaMatters podcast. Grad of @uwsmph. #medtwitter #somedocs
Articles
-
1 week ago |
medscape.com | Noelle K. LoConte |Kristine Torres-Lockhart |Nathaniel Chin
Summary and Key TakeawaysDr LoConte and the panel discuss the limits of using cancer incidence as the primary endpoint in alcohol-related studies. Because cancer develops slowly, more immediate clinical markers — such as liver function changes, cognitive effects, falls, and even motor vehicle accidents — are often better indicators of harm. The panel also explores the challenges of measuring alcohol intake from a patient perspective, highlighting how misleading the concept of “a drink” can be.
-
1 week ago |
medscape.com | Noelle K. LoConte |Kristine Torres-Lockhart |Nathaniel Chin
Summary and Key TakeawaysDr Nathaniel Chin reframes cognitive decline as a powerful entry point for patient-centered discussions about modifiable lifestyle factors, including alcohol. He explains how patients in their thirties to fifties are increasingly curious about preserving brain health, and how this opens the door to discussions about exercise, diet, and sleep — and eventually alcohol.
-
1 week ago |
medscape.com | Noelle K. LoConte |Kristine Torres-Lockhart |Nathaniel Chin
Summary and Key TakeawaysDr LoConte spotlights emerging research that now ties alcohol to cancers beyond the well-known “big seven,” including prostate, pancreatic, and stomach cancers. Despite this growing evidence, many physicians still don’t ask patients about alcohol use. She urges clinicians — especially oncologists — to normalize these conversations in everyday care, provide nonstigmatizing support, and acknowledge how deeply embedded drinking is in social norms.
-
Feb 10, 2025 |
jamanetwork.com | Fred Ketchum |Nathaniel Chin |Joshua D. Grill |Neurological Disorders
Aligning Alzheimer Disease Biology With Care Two new proposals were recently made to incorporate advances in the diagnosis and staging of Alzheimer disease (AD) biomarkers into clinical practice.
-
Sep 23, 2024 |
madison.com | Nathaniel Chin
Fear keeps some people awake at night. Their parents or grandparents had Alzheimer’s disease. Whenever they struggled to remember people’s names or forgot why they walked into a room, they worried if they were developing it, too. While that fear is understandable, someone’s family history of Alzheimer’s does not paint a full picture of their own risk for developing the disease. Many people with a family history will never develop Alzheimer’s.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 448
- Tweets
- 252
- DMs Open
- No
I’m excited to share this perspective essay in @NEJM. The role of primary care in evaluating cognitive change is critical. Biomarker testing is exciting, but it doesn’t simplify the process nor should it diminish the importance of a good history and clinical judgement.
As the number of people with dementia in the United States grows, many observers believe that diagnosis will have to happen in primary care. How can PCPs be prepared for this new and complex role? Perspective by Drs. @NathanielChinMD and @claireify_sci: https://t.co/XyuI5QqkHC https://t.co/jtlF9JPTlK
Thank you @ScottRobertsPhD for a great conversation on APOE testing and sharing results with research participants. Your insights will be helpful as the clinical field incorporates this testing more. The evaluation for using novel anti-amyloid therapies has brought many changes.
Genetics can play a significant role in one's risk for #Alzheimers, but how can people learn about their risk? @ScottRobertsPhD joins #DementiaMatters to discuss the importance of APOE disclosures, walk listeners through the process and more. Listen 🎧 https://t.co/oBjrnfrx8z https://t.co/Hj2L2MntOT
#Alzheimers affects an estimated 6.9 million Americans age 65 and older. If you appreciate the news, research and caregiver resources we provide on the #DementiaMatters podcast, consider donating to our fund through the @uwfoundation. Visit: https://t.co/7q5vYZq4JN https://t.co/xwbZnY9AjS
